486 filings
Page 14 of 25
8-K
41y4n9o
23 Mar 12
TearLab Corporation Reports 2011 Financial Results
12:00am
424B3
8ri0a2g
27 Feb 12
Prospectus supplement
12:00am
8-K
ygm21rsjc
27 Feb 12
Dr. Adrienne Graves Engaged to Explore Potential Commercial Partnership Opportunities for the TearLab Osmolarity System in Japan
12:00am
CT ORDER
zgmkzoua39sj860kggw
9 Feb 12
Confidential treatment order
12:00am
424B3
w5brzocr063s1t3e1b
29 Dec 11
Prospectus supplement
12:00am
8-K
nzocn4x6sc9yz0ai1rv0
29 Dec 11
Entry into a Material Definitive Agreement
12:00am
424B3
pb7lc62
14 Nov 11
Prospectus supplement
12:00am
8-K
qc8 1erlihj4rs2r5b
10 Nov 11
TearLab Corporation Reports Q3-11 Financial Results
12:00am
CT ORDER
56xwga5zc
31 Aug 11
Confidential treatment order
12:00am
424B3
acr pknl0cgwsouwj
17 Aug 11
Prospectus supplement
12:00am
EFFECT
jbopxwarxefk6pc 8i7p
17 Aug 11
Notice of effectiveness
12:00am
8-K
zi4tk9dk8qm
10 Aug 11
TearLab Corporation, Reports Q2-11 Financial Results
12:00am
8-K
rj8j33lovh xtdq
5 Aug 11
Entry into a Material Definitive Agreement
12:00am
D
0jjlhbc 5n2cqmoa
12 Jul 11
$14.15M in equity / options / securities to be acquired, sold $14.15M, 22 investors
12:00am
8-K
0ys161k8
6 Jul 11
Departure of Directors or Certain Officers
12:00am